Open University PhD degree at Stowers Institute
Meet our Students
Student Selection Procedures
Registration with the Open University
PhD Student Research Degree Requirements
Student Responsibilities
Student Training
Student Advisory Committee
Annual Report Guidelines
Graduate Programme Coordinating Committee
Student Pastoral Support
Research Code of Conduct
Student Grievance Procedure
Nature of Studentship Appointment and Termination
SIMR specific documents
(internal access only)
Open University Resources
Forms
Guidance Notes
Calendar
OU's PhD Skill Course (need Password) SMT895
|
Open University (UK)
PhD degree at Stowers Institute for Medical Research
Chengqi LIN
Stowers Institute for Medical Research
An Affiliated Research Centre of the Open University
The Super Elongation Complex (SEC) in development and leukemogenesis
The mixed-lineage leukaemia gene (MLL) was found to form a variety of chromosomal translocations each resulting in the pathogenesis of acute myeloid and lymphoid leukaemia. Although these cytogenetic abnormalities were discovered over thirty years ago, little is known about the biochemical functions of MLL or how its translocations results in the development of leukaemia. The translocation partners of MLL share very little sequence or seemingly functional similarities. However, their translocations result in up-regulation of several genes within the Hox cluster and therefore the pathogenesis of leukaemia. To define the molecular reason why these translocations result in leukaemogenesis, my co-authors and I purified several of the commonly occurring MLL chimeras. We have identified many of the MLL partners within a novel super elongation complex (SEC), including ELL, P-TEFb and AFF4. AFF4 is required for SEC stability and proper transcription by poised RNA polymerase II in metazoans. Knockdown of AFF4 within SEC in leukaemic cells shows reduction in MLL chimera target gene expression suggesting that AFF4 could be a key regulator in the pathogenesis of leukaemia through many of the MLL partners. We are in the process of identifying downstream targets of SEC in normal and leukaemic cells in the hope of developing targeted therapeutic for MLL translocation based leukaemia.
The Stowers Institute for Medical Research is a non-profit, basic biomedical research organization dedicated to improving human health by studying the fundamental processes of life. Jim Stowers, founder of American Century Investments, and his wife Virginia opened the Institute in 2000. Since then, the Institute has spent over a half billion dollars in pursuit of its mission. Currently the Institute is home to nearly 500 researchers and support personnel; over 20 independent research programs; and more than a dozen technology development and core facilities. Learn more about the Institute at www.stowers.org.
See also the Stowers Press Release on our website:
http://www.stowers.org/WhatsNew/pr2009/PR090109.asp
|